We are live on
!
Find out more
SCM
Stonebridge Capital Management Portfolio holdings
AUM
$220M
This Fund
S&P 500
This Quarter
Est. Return
+3.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$20.2M
(-7.4%)
Cap. Flow
-$28.1M
Cap. Flow
% of AUM
-11.07%
Top 10 Holdings %
Top 10 Hldgs %
38.34%
Holding
155
New
6
Increased
10
Reduced
81
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.11M |
| 2 |
DaVita
DVA
|
+$579K |
| 3 |
Alcon
ALC
|
+$234K |
| 4 |
United Parcel Service
UPS
|
+$207K |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$1.51M |
| 2 |
Gilead Sciences
GILD
|
+$1.47M |
| 3 |
Walt Disney
DIS
|
+$1.21M |
| 4 |
Novartis
NVS
|
+$998K |
| 5 |
Microsoft
MSFT
|
+$982K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.55% |
| 2 | Healthcare | 17.46% |
| 3 | Industrials | 11.58% |
| 4 | Consumer Staples | 9.42% |
| 5 | Energy | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.99T
| $12.5M | 4.94% |
93,639
-7,738
| -8% | -$982K |
|
2
Cisco
CSCO
$436B
| $10.5M | 4.12% |
191,012
-4,100
| -2% | -$226K |
|
3
Johnson & Johnson
JNJ
$599B
| $9.39M | 3.7% |
67,437
-4,758
| -7% | -$659K |
|
4
Intel
INTC
$488B
| $9.18M | 3.62% |
191,848
-6,350
| -3% | -$315K |
|
5
Oracle
ORCL
$350B
| $9.18M | 3.62% |
161,086
-7,600
| -5% | -$411K |
|
6
Apple
AAPL
$4.8T
| $9.16M | 3.61% |
185,120
-19,820
| -10% | -$966K |
|
7
PepsiCo
PEP
$185B
| $8.88M | 3.5% |
67,710
-1,551
| -2% | -$199K |
|
8
Chevron
CVX
$378B
| $8.3M | 3.27% |
66,729
-5,545
| -8% | -$670K |
|
|
9
Walt Disney
DIS
$167B
| $8.22M | 3.24% |
58,880
-9,120
| -13% | -$1.21M |
|
10
Stryker
SYK
$122B
| $7.2M | 2.84% |
35,010
-400
| -1% | -$76.4K |
|
11
ExxonMobil
XOM
$615B
| $7.12M | 2.81% |
92,873
-9,008
| -9% | -$697K |
|
12
Coca-Cola
KO
$353B
| $6.68M | 2.63% |
131,150
-16,181
| -11% | -$793K |
|
13
General Dynamics
GD
$100B
| $6.19M | 2.44% |
34,033
-1,350
| -4% | -$232K |
|
14
Intuit
INTU
$80.4B
| $5.62M | 2.21% |
21,489
-470
| -2% | -$119K |
|
15
Dentsply Sirona
XRAY
$2.7B
| $5.36M | 2.11% |
91,754
-8,035
| -8% | -$432K |
|
|
16
Starbucks
SBUX
$119B
| $5.35M | 2.11% |
63,857
-19,231
| -23% | -$1.51M |
|
17
IBM
IBM
$200B
| $5.02M | 1.98% |
38,058
-4,230
| -10% | -$556K |
|
|
18
Gilead Sciences
GILD
$165B
| $3.66M | 1.44% |
54,238
-22,319
| -29% | -$1.47M |
|
19
Boeing
BA
$165B
| $3.49M | 1.38% |
9,598
-450
| -4% | -$164K |
|
20
Alphabet (Google) Class C
GOOG
$4.29T
| $3.43M | 1.35% |
63,400
-13,580
| -18% | -$783K |
|
21
JPMorgan Chase
JPM
$901B
| $3.36M | 1.33% |
30,071
-8,250
| -22% | -$910K |
|
|
22
Novartis
NVS
$285B
| $3.35M | 1.32% |
36,750
-11,790
| -24% | -$998K |
|
23
Merck
MRK
$307B
| $3.09M | 1.22% |
38,661
-10,616
| -22% | -$813K |
|
24
Procter & Gamble
PG
$347B
| $3.09M | 1.22% |
28,156
| – | – |
|
25
Caterpillar
CAT
$398B
| $2.96M | 1.17% |
21,687
-200
| -0.9% | -$26.4K |
|
Similar funds
TLCM
RM
EFMH
DA
WDC
MDCM
LPP
AWM
Stonebridge Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stonebridge Capital Management held 155 positions worth $254M, down 7.4% from $274M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Stonebridge Capital Management withdrew a net $28.1M in Q2 2019, closing 12 positions and reducing 81 holdings. Its most notable exit was Biogen, an estimated $634K position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stonebridge Capital Management opened a new position in Alcon worth $247K.
- Stonebridge Capital Management's largest Q2 2019 buy was Alcon: 3,988 shares worth $247K.
- Stonebridge Capital Management added most to Bristol-Myers Squibb in Q2 2019, an estimated $1.11M increase.
- Stonebridge Capital Management's biggest Q2 2019 reduction was Starbucks, cutting an estimated $1.51M.
- Stonebridge Capital Management fully exited Biogen in Q2 2019, selling an estimated $634K.
- Stonebridge Capital Management's ten largest holdings make up 38% of its $254M portfolio in Q2 2019.
- Stonebridge Capital Management opened 6 new positions and closed 12 in Q2 2019.
- Stonebridge Capital Management's portfolio value fell 7.4% quarter-over-quarter to $254M.
Based on Stonebridge Capital Management's 13F filing for Q2 2019, filed 12 Jul 2019.